These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9887991)

  • 1. [DuPont-Pharma Laboratories. Sustiva].
    Allerg Immunol (Paris); 1998 Nov; 30(9):302. PubMed ID: 9887991
    [No Abstract]   [Full Text] [Related]  

  • 2. CSF replication reduced with Sustiva.
    AIDS Patient Care STDS; 1998 Oct; 12(10):802. PubMed ID: 11362028
    [No Abstract]   [Full Text] [Related]  

  • 3. [FDA approval of the first HIV anti-retroviral from DuPont-Pharma: SUSTIVA (efavirenz). SUSTIVA should be associated with other anti-retrovirals and could be considered a new alternative first line treatment].
    Allerg Immunol (Paris); 1998 Oct; 30(8):268-70. PubMed ID: 9846197
    [No Abstract]   [Full Text] [Related]  

  • 4. New study shows efavirenz effective with d4T and 3TC.
    AIDS Alert; 1999 May; 14(5):60. PubMed ID: 11366404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HIV infection: DuPont Pharma presents the results of its antiretroviral agent].
    Allerg Immunol (Paris); 1998 Apr; 30(4):123-4. PubMed ID: 9631694
    [No Abstract]   [Full Text] [Related]  

  • 6. DuPont initiates Sustiva oral liquid expanded access program.
    AIDS Read; 2000 Jun; 10(6):339. PubMed ID: 10881361
    [No Abstract]   [Full Text] [Related]  

  • 7. Don't mix Sustiva with Fortovase.
    Posit Aware; 1998; 9(5):17. PubMed ID: 11365885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More expanded access for DMP 266.
    Vazquez E
    Posit Aware; 1998; 9(2):15. PubMed ID: 11365220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of abacavir and efavirenz: new antiretroviral drugs to treat HIV-1 infection.
    Wolbach J; Capoccia K
    Nurse Pract; 1999 Jun; 24(6):81-2, 87-90, 92. PubMed ID: 10431297
    [No Abstract]   [Full Text] [Related]  

  • 10. Viral escape in cerebrospinal fluid--an achilles heel of HIV therapy?
    Clifford DB
    J Infect Dis; 2010 Dec; 202(12):1768-9. PubMed ID: 21050117
    [No Abstract]   [Full Text] [Related]  

  • 11. Dupont data supports earlier findings.
    Slovick J
    Posit Living; 1999 Nov; 8(10):45. PubMed ID: 11367331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustiva granted full FDA approval.
    AIDS Read; 2000 Mar; 10(3):147. PubMed ID: 10798886
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid decay of HIV RNA in the cerebrospinal fluid during antiretroviral combination therapy.
    Stellbrink HJ; Eggers C; van Lunzen J; Albrecht H; Greten H
    AIDS; 1997 Nov; 11(13):1655-7. PubMed ID: 9365775
    [No Abstract]   [Full Text] [Related]  

  • 14. Expanded access.
    Notes Undergr; 1997 Nov; (No 36):6. PubMed ID: 11365207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of first line therapy including efavirenz and two nucleoside reverse transcriptase inhibitors in HIV-infected children.
    Funk MB; Notheis G; Schuster T; Elanjkal Z; von Hentig N; Stürmer M; Linde R; Dunsch D; Königs C; Wintergerst U; Kreuz W
    Eur J Med Res; 2005 Dec; 10(12):503-8. PubMed ID: 16356864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy.
    Tashima KT; Caliendo AM; Ahmad M; Gormley JM; Fiske WD; Brennan JM; Flanigan TP
    J Infect Dis; 1999 Sep; 180(3):862-4. PubMed ID: 10438381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Now approved: Sustiva in combination offers patients a new first-line therapy.
    Fac Notes (New Orleans La); 1998; 10(6):10. PubMed ID: 11366140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Decrease of HIV-1 virus load by nevirapin/efavirenz].
    Dtsch Med Wochenschr; 2003 May; 128(19):1075. PubMed ID: 12774797
    [No Abstract]   [Full Text] [Related]  

  • 19. DMP 266 and indinavir combination.
    AIDS Patient Care STDS; 1997 Aug; 11(4):287-8. PubMed ID: 11361845
    [No Abstract]   [Full Text] [Related]  

  • 20. [Efavirenz--comprehensive status of studies].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():79-81. PubMed ID: 16385886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.